摘要

<正>1文献来源Cannon CP,Blazing MA,Giugliano RP,et al.The IMPROVE-IT investigators.Ezetimibe added to statin therapy after acute coronary syndromes[J].N Engl J Med,2015,372(25):2387-2397.2证据水平1a。3背景低密度脂蛋白胆固醇(low-density lipoprotein,LDL-C)是动脉粥样硬化最重要的致病因素。

全文